TL;DR
Turn your wind-down time into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
Researchers identified 16 blood molecules that increase across menopause and are implicated in brain aging and dementia risk. Higher levels of the proteins were associated with poorer cognitive outcomes and, in one large cohort, a modestly greater risk of Alzheimer’s dementia over 16 years; the findings do not show that menopause causes Alzheimer’s disease.
Researchers studying women across different stages of menopause identified 16 blood molecules that rise during the transition and are implicated in brain aging and dementia risk. The study, published in Nature Medicine, found that higher levels of these proteins were associated with poorer cognitive outcomes and, in the largest older-women cohort, a modestly greater risk of Alzheimer’s dementia over 16 years—but it does not show that menopause causes the disease.
The team used advanced protein analysis to examine thousands of proteins in women who were premenopausal, perimenopausal or postmenopausal in the UC Santa Barbara Healthy Aging Study. They identified changes in proteins related to inflammation and neuronal processes, including molecules associated with Alzheimer’s disease. In those data, protein shifts tracked more closely with menopause stage than with participants’ exact ages.
The researchers tested their findings against data from more than 2,800 women in the UK Biobank. That analysis also linked menopause with molecular signatures associated with accelerated aging across multiple organ systems. To examine possible connections with brain health, the team then analyzed four independent cohorts comprising nearly 12,000 older women. Higher levels of the identified “risk” proteins were associated with poorer cognitive outcomes; in the largest cohort, the signature was associated with a modestly higher likelihood of Alzheimer’s dementia over the subsequent 16 years.
The study was led by Madeline Wood Alexander of Sunnybrook Research Institute and Rowan Saloner and Kaitlin Casaletto of the University of California, San Francisco. Emily Jacobs of UC Santa Barbara was also among the authors. The researchers describe the protein pattern as a potential way to study biological changes around menopause, not as a diagnostic test or proof that an individual will develop dementia.
Menopause as a Brain-Health Window
The findings add evidence that the menopause transition is associated with measurable biological changes beyond reproductive hormones, and that some of those changes may relate to brain health later in life. Because menopause stage was more closely linked to the protein shifts than exact age in the study data, the results give researchers a reason to investigate whether this midlife period has distinct relevance to later cognitive health.
The potential practical value is still prospective. The team hopes to develop a blood test that could help identify people who might benefit from early prevention strategies, using cholesterol testing as an analogy for risk assessment. The study does not establish that such a test is ready for clinical use, nor does it identify an intervention proven to prevent dementia. Its present contribution is to point toward candidate molecular signals for future research.
Senior author Kaitlin Casaletto said midlife is a period when brain resilience or vulnerability may be shaped, and that menopause could be a particularly important opportunity to study intervention for women. That is a research rationale, not evidence that an intervention based on these proteins will improve outcomes.
Popular right now
Dyson Ball Animal 3 Upright Vacuum – Corded, 290 AW, De‑tangling Motorbar Cleaner Head, 3 Suction Modes
Dreame G10 Pro Wet and Dry Vacuum Mop
Ninja CM401 Specialty Coffee Maker with 10-Cup Carafe and Fold-Away Frother
As an affiliate, we earn on qualifying purchases.
How the Study Tracked Protein Changes
Menopause involves endocrine changes and can coincide with symptoms such as hot flashes, sleep disturbance and brain fog. The researchers frame it as a broader biological transition, while examining whether blood proteins changing around that period relate to later measures of cognition. Their approach combines protein measurements across menopause stages with follow-up evidence from separate groups of older women.
The paper, titled “Blood proteomics of menopause map to brain aging and dementia risk,” appeared in Nature Medicine in 2026. The authors say earlier work has left substantial gaps in understanding how menopause-related biology connects to later-life brain health. Jacobs said women spend roughly one-third of their lives after menopause, while the biology linking the transition to later brain health remains poorly understood. The work received support in part from the Ann S. Bowers Women’s Brain Health Initiative, Wellcome Leap, the National Institutes of Health and the Noyce Trust.
“Menopause is not an isolated reproductive event. It is a whole-body biological transition.”
— Emily Jacobs, professor of psychological and brain sciences at UC Santa Barbara
Association Is Not Causation
The study does not establish that menopause causes Alzheimer’s disease, or that the 16 molecules themselves cause dementia. The researchers note that most women do not develop Alzheimer’s and that the clinical meaning of individual Alzheimer’s-related protein changes detected in midlife remains uncertain. The reported association in the largest cohort was modest, and the results do not show how accurately the protein signature predicts outcomes for any one person.
The researchers also say that studies following the same women over time are needed to clarify how hormone changes, proteins, symptoms and brain health develop together. The findings do not establish which biological changes drive the associations, whether they can be modified, or whether acting on them would change cognitive or dementia outcomes.
Longitudinal Research Underway
UC Santa Barbara researchers and collaborators are launching the Longitudinal Menopause Project to follow women across the menopause transition. The authors say this kind of repeated measurement will be needed to map how hormonal and protein changes relate to symptoms and brain health over time. The team is recruiting researchers for the project.
Further studies will need to test whether the reported protein patterns are reproducible, how well they predict later outcomes, and whether any midlife interventions can improve brain-health measures. A clinical blood test remains a goal rather than an established product; the source material does not give a release date or specify when it might be available.
Key Questions
Does the study show that menopause causes Alzheimer’s disease?
No. The researchers report associations between menopause-related protein patterns and later cognitive outcomes. They explicitly say the findings do not mean menopause causes Alzheimer’s.
What did researchers identify?
They identified 16 molecules whose levels increased across the menopause transition and that are implicated in brain aging and dementia risk. The study does not establish that the molecules themselves cause disease.
How many women were included in the brain-health analyses?
The researchers examined four independent cohorts totaling nearly 12,000 older women. In the largest cohort, the protein signature was associated with a modestly greater risk of Alzheimer’s dementia over 16 years.
Is a blood test available to predict dementia risk?
No test is reported as ready for clinical use. The researchers describe developing a blood test as a future goal, and its accuracy and clinical value remain to be established.
What research comes next?
The team is launching the Longitudinal Menopause Project to follow women across the transition and study how hormones, proteins, symptoms and brain health change together over time.
Source: news-medical.net
